DCF — COBRE VALLEY REG. MEDICAL CENTER
Enterprise Value: $-121.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-121.1M
Enterprise Value
$-38.4M
PV of Cash Flows
$-82.8M
PV of Terminal Value
$-133.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $77.1M | $-7.5M | -10.0% | $-10.8M | $-9.8M |
| Year 2 | $79.4M | $-7.0M | -9.0% | $-10.3M | $-8.5M |
| Year 3 | $81.8M | $-6.3M | -8.0% | $-9.8M | $-7.4M |
| Year 4 | $84.3M | $-6.1M | -7.0% | $-9.7M | $-6.6M |
| Year 5 | $86.8M | $-6.1M | -7.0% | $-9.8M | $-6.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-121.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$74.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10251223347691936
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5